NO20004215D0 - Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav - Google Patents

Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav

Info

Publication number
NO20004215D0
NO20004215D0 NO20004215A NO20004215A NO20004215D0 NO 20004215 D0 NO20004215 D0 NO 20004215D0 NO 20004215 A NO20004215 A NO 20004215A NO 20004215 A NO20004215 A NO 20004215A NO 20004215 D0 NO20004215 D0 NO 20004215D0
Authority
NO
Norway
Prior art keywords
angiotensin
type
pharmaceutical composition
receptor agonist
agonist
Prior art date
Application number
NO20004215A
Other languages
English (en)
Other versions
NO20004215L (no
Inventor
Lars Fondriks
Anders Pettersson
Anders Hallberg
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Publication of NO20004215D0 publication Critical patent/NO20004215D0/no
Publication of NO20004215L publication Critical patent/NO20004215L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20004215A 1998-02-24 2000-08-23 Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav NO20004215L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800550A SE9800550D0 (sv) 1998-02-24 1998-02-24 A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PCT/SE1999/000262 WO1999043339A1 (en) 1998-02-24 1999-02-24 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof

Publications (2)

Publication Number Publication Date
NO20004215D0 true NO20004215D0 (no) 2000-08-23
NO20004215L NO20004215L (no) 2000-09-18

Family

ID=20410283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004215A NO20004215L (no) 1998-02-24 2000-08-23 Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav

Country Status (18)

Country Link
EP (1) EP1066048A1 (no)
JP (1) JP2002504516A (no)
KR (1) KR20010041211A (no)
CN (1) CN1291104A (no)
AU (1) AU755949B2 (no)
BR (1) BR9908188A (no)
CA (1) CA2319123A1 (no)
EE (1) EE200000481A (no)
HU (1) HUP0101411A3 (no)
ID (1) ID26639A (no)
IL (1) IL137990A0 (no)
IS (1) IS5594A (no)
MX (1) MXPA00008172A (no)
NO (1) NO20004215L (no)
NZ (1) NZ506188A (no)
SE (1) SE9800550D0 (no)
SK (1) SK11522000A3 (no)
WO (1) WO1999043339A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
WO2001043761A2 (en) * 1999-12-16 2001-06-21 University Of Southern California Methods for treating and preventing damage to mucosal tissue
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
CA2604797C (en) 2005-04-12 2013-05-28 Vicore Pharma Ab New tricyclic angiotensin ii agonists
MX2007012633A (es) 2005-04-12 2008-01-11 Vicore Pharma Ab Nuevos agonistas biciclicos de angiotensina ii.
KR101284573B1 (ko) 2005-04-12 2013-07-11 바이코어 파마 아베 신규한 트리시클릭 안지오텐신 ⅱ 아고니스트
KR101423898B1 (ko) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
US20150119329A1 (en) * 2012-04-16 2015-04-30 New York University Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral
AU2016227486A1 (en) 2015-03-02 2017-08-17 Vicore Pharma Ab Angiotensin ll receptor agonist for treating pulmonary fibrosis
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
WO2021023698A1 (en) 2019-08-02 2021-02-11 Lanthiopep B.V Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
PH12022552413A1 (en) 2020-03-19 2024-01-08 Vicore Pharma Ab Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006081D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
EP4313953A1 (en) 2021-03-23 2024-02-07 Vicore Pharma AB Selective angiotensin ii receptor ligands
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
CA3222721A1 (en) 2021-07-09 2023-01-12 Nadia Nasser PETERSEN New selective angiotensin ii compounds
GB202115303D0 (en) 2021-10-25 2021-12-08 Vicore Pharma Ab New formulation
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use
CA3249539A1 (en) 2022-02-10 2023-08-17 Vicore Pharma Ab USE OF BULOXIBUTID FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
KR20250002355A (ko) 2022-04-06 2025-01-07 우한 휴먼웰 이노베이티브 드러그 리서치 앤드 디벨롭먼트 센터 리미티드 컴퍼니 Ａｔ２ｒ 작용제
GB2640807A (en) 2022-12-22 2025-11-05 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
CN120569378A (zh) 2023-01-09 2025-08-29 维科尔药物公司 选择性血管紧张素ii化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO1996014060A1 (en) * 1994-11-04 1996-05-17 Marklund Stefan L Use of receptor agonists to stimulate superoxide dismutase activity
SE9501881D0 (sv) * 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII-receptor antagonists
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
SE9502219D0 (sv) * 1995-06-19 1995-06-19 Astra Ab Novel medical use

Also Published As

Publication number Publication date
AU2753799A (en) 1999-09-15
CN1291104A (zh) 2001-04-11
HUP0101411A3 (en) 2002-11-28
EE200000481A (et) 2002-02-15
WO1999043339A1 (en) 1999-09-02
IL137990A0 (en) 2001-10-31
SK11522000A3 (sk) 2001-04-09
MXPA00008172A (es) 2002-06-21
NZ506188A (en) 2003-04-29
BR9908188A (pt) 2000-10-24
ID26639A (id) 2001-01-25
CA2319123A1 (en) 1999-09-02
KR20010041211A (ko) 2001-05-15
JP2002504516A (ja) 2002-02-12
EP1066048A1 (en) 2001-01-10
AU755949B2 (en) 2003-01-02
SE9800550D0 (sv) 1998-02-24
IS5594A (is) 2000-08-21
HUP0101411A2 (hu) 2002-03-28
NO20004215L (no) 2000-09-18

Similar Documents

Publication Publication Date Title
NO20004215L (no) Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
DK1019077T3 (da) Hidtil ukendte exendinagonistforbindelser
DZ2788A1 (fr) Agonistes et antagonistes selectifs à IL-2.
PT1177178E (pt) Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
NO305435B1 (no) Ïstrogen-agonist/antagonister, farmas°ytisk preparat inneholdende disse og mellomprodukt derav
NO20043803L (no) Substituerte amider som er aktive i cannabinoid 1-reseptoren
NO994906D0 (no) GnRH antagonister som er modifisert i stillinger 5 og 6
NO20001612D0 (no) Oralt preparat
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
NO20001160L (no) Nytt skumdannende farmasøytisk preparat
NO20012915L (no) Ny farmasöytisk formulering
IT1312366B1 (it) Resina copolimerica, sua preparazione e photoresist che la utilizza.
DK0733626T3 (da) N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
NO306257B1 (no) 11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav
NO20005399L (no) Farmasöytisk preparat
NO20006138D0 (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
NO996115L (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO20004316D0 (no) Meta azasykliske aminobenzosyreforbindelser og derivater derav som er integrinatantagonister
NO20004668D0 (no) 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
DK1237559T3 (da) Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran
NO20004277L (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
NO20022103D0 (no) Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application